Cargando…

Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models

Gastric cancer is the fifth most common malignancy and the third leading cause of cancer‐related death worldwide. Activation of c‐MET increases tumour cell survival through the initiation of the DNA damage repair pathway. PARP is an essential key in the DNA damage repair pathway. The primary role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koustas, Evangelos, Karamouzis, Michalis V., Sarantis, Panagiotis, Schizas, Dimitrios, Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521333/ https://www.ncbi.nlm.nih.gov/pubmed/32686903 http://dx.doi.org/10.1111/jcmm.15655

Ejemplares similares

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Upgraded role of autophagy in colorectal carcinomas
por: Koustas, Evangelos, et al.
Publicado: (2018)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
por: Koustas, Evangelos, et al.
Publicado: (2019)

Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020)

The Implication of Autophagy in Gastric Cancer Progression
por: Koustas, Evangelos, et al.
Publicado: (2021)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status
por: Koustas, Evangelos, et al.
Publicado: (2018)

Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
por: Shalit, Almog, et al.
Publicado: (2023)

The Controversial Role of Autophagy in Ewing Sarcoma Pathogenesis—Current Treatment Options
por: Koustas, Evangelos, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
por: Garmpis, Nikolaos, et al.
Publicado: (2021)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
por: Koustas, Evangelos, et al.
Publicado: (2022)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
por: Papatheofani, Vasiliki, et al.
Publicado: (2021)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Investigational Drug Treatments for Triple-Negative Breast Cancer
por: Damaskos, Christos, et al.
Publicado: (2021)

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
por: Zoi, Ilianna, et al.
Publicado: (2019)

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007)

The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches
por: Koustas, Evangelos, et al.
Publicado: (2022)

Mechanosensitive Stem-Cell Genes and Klotho in Atherosclerotic Aortas: Regulating Spatially Deranged Expression Patterns Using Colchicine Regimens
por: Mylonas, Konstantinos S., et al.
Publicado: (2022)

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
por: Koustas, Evangelos, et al.
Publicado: (2023)

An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches
por: Koustas, Evangelos, et al.
Publicado: (2023)

Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
por: D’Ambrosio, Concetta, et al.
Publicado: (2022)

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
por: Anestis, Aristomenis, et al.
Publicado: (2020)

Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study
por: Poulia, Kalliopi-Anna, et al.
Publicado: (2022)

The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
por: Karamouzis, Michalis V., et al.
Publicado: (2021)

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas
por: Karamouzis, Michalis V., et al.
Publicado: (2015)

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
por: Grojean, Meghan, et al.
Publicado: (2021)

The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)

Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
por: Du, Yi, et al.
Publicado: (2016)

EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2007)

Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
por: Garmpis, Nikolaos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3p6omhhltci3339vb83reomhn